Wednesday, 26 February 2014

Alzheimer Disease Market to reach $6.49 billion by 2022

There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapies are relatively safe and effective, these therapies are still lacking because of they cannot maintain their effects and lack mechanisms that alter the course of the disease.



from Africa Punch http://ift.tt/1c8RCI2

via IFTTThttp://ift.tt/1c8RCI2

No comments:

Post a Comment